Cargando…

Secondary myelodysplastic syndrome/acute myeloid leukaemia following mitoxantrone-based therapy for breast carcinoma

Of 1774 patients with breast cancer given mitoxantrone (MTZ) with methotrexate (n = 492) or with methotrexate and mitomycin C (n = 1282), nine developed MDS/AML after a median of 2.5 years. Median duration of survival from diagnosis of MDS/AML was 10 months and six patients died. The crude incidence...

Descripción completa

Detalles Bibliográficos
Autores principales:	Saso, R, Kulkarni, S, Mitchell, P, Treleaven, J, Swansbury, G J, Mehta, J, Powles, R, Ashley, S, Kuan, R, Powles, T
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2000
Materias:	Regular Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2374543/ https://www.ncbi.nlm.nih.gov/pubmed/10883674 http://dx.doi.org/10.1054/bjoc.2000.1196

Ejemplares similares

Glomerular filtration rate prior to high-dose melphalan 200 mg/m(2) as a surrogate marker of outcome in patients with myeloma
por: Sirohi, B, et al.
Publicado: (2001)

High-dose cytosine arabinoside plus etoposide as initial treatment for acute myeloid leukaemia: a single centre study.
por: Parikh, P., et al.
Publicado: (1990)

The response of human myeloid leukaemia xenografts to human recombinant tumour necrosis factor.
por: Clutterbuck, R. D., et al.
Publicado: (1989)

Spontaneous regression of human acute myeloid leukaemia xenografts and phenotypic evidence for maturation.
por: Palú, G., et al.
Publicado: (1979)

Further evidence of response by leukaemia patients in remission to antigen(s) related to acute myelogenous leukaemia.
por: Cocks, P., et al.
Publicado: (1977)

Comparison of marrow vs blood-derived stem cells for autografting in previously untreated multiple myeloma.
por: Raje, N., et al.
Publicado: (1997)

Indoor residential radon exposure and risk of childhood acute myeloid leukaemia
por: Steinbuch, M, et al.
Publicado: (1999)

Adult Acute Leukaemia
por: Atkinson, K., et al.
Publicado: (1974)

Mitoxantrone and ametantrone induce interstrand cross-links in DNA of tumour cells
por: Skladanowski, A, et al.
Publicado: (2000)

Effects of bryostatin-1 on chronic myeloid leukaemia-derived haematopoietic progenitors
por: Thijsen, S F T, et al.
Publicado: (1999)

A high incidence of vertebral fracture in women with breast cancer
por: Kanis, J A, et al.
Publicado: (1999)

p53 status of newly established acute myeloid leukaemia cell lines
por: Zheng, A, et al.
Publicado: (1999)

Phase II trial of cytarabine and mitoxantrone with devimistat in acute myeloid leukemia
por: Anderson, Rebecca, et al.
Publicado: (2022)

Failure of short-term treatment with flurbiprofen to enhance the therapeutic effect of cyclophosphamide against rodent sarcomas and a leukaemia.
por: Heckford, S. E., et al.
Publicado: (1982)

Atypical chronic myeloid leukaemia – a rare subtype of myelodysplastic/myeloproliferative neoplasm
por: Drozd-Sokołowska, Joanna E., et al.
Publicado: (2018)

Characterisation of the GRAF gene promoter and its methylation in patients with acute myeloid leukaemia and myelodysplastic syndrome
por: Bojesen, S E, et al.
Publicado: (2006)

Randomized trial to compare the efficacy and toxicity of cyclophosphamide, methotrexate and 5-fluorouracil (CMF) with methotrexate mitoxantrone (MM) in advanced carcinoma of the breast
por: Harper-Wynne, C, et al.
Publicado: (1999)

A comparison of the incidence of the myelodysplastic syndrome and acute myeloid leukaemia following melphalan and cyclophosphamide treatment for myelomatosis. A report to the Medical Research Council's working party on leukaemia in adults.
por: Cuzick, J., et al.
Publicado: (1987)

Immunotherapy for Acute Myelogenous Leukaemia
por: Powles, R. L., et al.
Publicado: (1973)

Angiogenesis in myelodysplastic syndromes
por: Pruneri, G, et al.
Publicado: (1999)

An Association Between Hypoplastic Myelodysplastic Syndrome and T-Prolymphocytic Leukaemia
por: Arathi, C A, et al.
Publicado: (2011)

Tobacco and the risk of acute leukaemia in adults
por: Kane, E V, et al.
Publicado: (1999)

A prospective biomarker analysis of alvocidib followed by cytarabine and mitoxantrone in MCL-1-dependent relapsed/refractory acute myeloid leukemia
por: Zeidner, Joshua F., et al.
Publicado: (2021)

Clinical significance of nuclear non-phosphorylated beta-catenin in acute myeloid leukaemia and myelodysplastic syndrome
por: Xu, Jinglan, et al.
Publicado: (2008)

Serial monitoring of circulating tumour DNA on clinical outcome in myelodysplastic syndromes and acute myeloid leukaemia
por: Zhou, Xinping, et al.
Publicado: (2023)

Haemostatic changes and thromboembolic risk during tamoxifen therapy in normal women.
por: Jones, A. L., et al.
Publicado: (1992)

Early discontinuation of empirical antibiotic treatment in neutropenic patients with acute myeloid leukaemia and high-risk myelodysplastic syndrome
por: Niessen, F. A., et al.
Publicado: (2020)

CLAG-M with dose-escalated mitoxantrone for adults with acute myeloid leukemia
por: Halpern, Anna B., et al.
Publicado: (2018)

Mitoxantrone and Etoposide for the Treatment of Acute Myeloid Leukemia Patients in First Relapse
por: Im, Annie, et al.
Publicado: (2016)

Association of childhood leukaemia with factors related to the immune system
por: Schüz, J, et al.
Publicado: (1999)

Immunotherapy for acute myelogenous leukaemia: a controlled clinical study 2 1/2 years after entry of the last patient.
por: Powles, R. L., et al.
Publicado: (1977)

Fibrinous pericarditis secondary to recurrent acute myeloid leukaemia
por: Konishi, Takao, et al.
Publicado: (2023)

Treosulfan for acute myeloid leukaemia and myelodysplastic syndrome in adults, and malignant and non-malignant haematological diseases in children
Publicado: (2023)

Patterns of maturation in short-term culture of human acute myeloid leukaemic cells.
por: Palú, G., et al.
Publicado: (1979)

Myeloid leukaemia following therapy for a first primary cancer.
por: Nandakumar, A., et al.
Publicado: (1991)

Mitoxantrone pleurodesis to palliate malignant pleural effusion secondary to ovarian cancer
por: Barbetakis, Nikolaos, et al.
Publicado: (2004)

Infections, vaccinations, and the risk of childhood leukaemia
por: Dockerty, J D, et al.
Publicado: (1999)

Transformation of myelodysplastic syndrome to mixed phenotype acute leukaemia
por: Do, Louis, et al.
Publicado: (2020)

Decitabine/cedazuridine for chronic myelomonocytic leukaemia, myelodysplastic syndromes
Publicado: (2022)

The role of the atypical chemokine receptor CCRL2 in myelodysplastic syndrome and secondary acute myeloid leukemia
por: Karantanos, Theodoros, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_684efhb3jm9tcbm3vkq7809r4n